市場調查報告書
商品編碼
1209804
全球腹腔鏡設備市場:到 2028 年的預測——按產品類型(腹腔鏡、吸引器、其他產品類型)、應用(泌尿外科、婦科外科、其他應用)最終用戶、地區分析Laparoscopy Instruments Market Forecasts to 2028 - Global Analysis By Product Type (Laparoscopes, Insufflators and Other Product types), Application (Urological Surgery, Gynecological Surgery and Other Application) End User and By Geography |
根據 Stratistics MRC,全球腹腔鏡器械市場規模將在 2022 年達到 140.8 億美元,到 2028 年將達到 317.3 億美元,在預測期內增長 14.5%。預計將以複合年增長率。
腹腔鏡手術是指在照相機的幫助下通過一個或多個小切口而不是腹壁的大(通常是一個)切口進行外科手術的器械。 腹腔鏡手術的優點是微創、無痛、不留疤痕。 此外,還具有美容效果、減輕腹壁負擔、縮短住院時間、恢復日常生活快、出血少、止血可靠等優點。
根據 Ergie P.Inocian 等人的說法,中東的減肥手術數量正在增加,以解決肥胖和代謝紊亂問題。 因此,減肥手術繼續被中東和北非地區接受為治療嚴重肥胖症的方法,預計將對市場增長產生積極影響。
市場動態
驅動程序
與開放手術相比,越來越傾向於微創手術
腹腔鏡手術具有住院時間短、失血少、並發症少、恢復時間短、療效好、感染風險低、切口小、疼痛小等優點,是首選,因為它與傳統手術相比,它具有許多優勢,例如更少的瘀傷。 隨著對腹腔鏡手術的需求急劇增加,預計在預測期內對腹腔鏡手術器械的需求也會擴大。
抑製劑
缺乏訓練有素的醫療保健專業人員
腹腔鏡手術對醫療助理控制外科醫生的可視化提出了挑戰。 疲勞、技術錯誤、完成手術的時間和儀器處理水平都會增加。 由於感染、過敏反應、器官損傷、粘連、血塊、內出血和小穿刺導致的運動範圍縮小,也可能會很困難。 在某些情況下,不穩定的攝像機平台、有限的運動會抑制市場增長,並且不允許外科醫生有效地進行手術。
機會
生活方式的改變
市場增長的動力來自越來越多的患有子宮肌瘤和子宮內膜異位症等健康問題的患者、子宮切除術和子宮切除手術數量的增加以及新興國家對改善醫療基礎設施的意識增強。. 此外,醫療腹腔鏡機器人、腹腔鏡、腹腔鏡可重複使用的微創設備、腹腔鏡滑鎖抓取器、腹腔鏡抽吸沖洗裝置和專用腹腔鏡設備等設備正在推動市場增長。
威脅
新興國家對腹腔鏡手術的基礎設施支持減少
但是,在新興國家/地區,可用於支持先進醫療實踐(例如腹腔鏡檢查)的基礎設施存在重大差距。 新興國家的醫療保健系統難以提供支持腹腔鏡手術等先進手術技術的基礎設施和資源,導致這些國家進行的腹腔鏡手術數量下降,並阻礙了腹腔鏡設備市場的發展。
COVID-19 的影響
COVID-19 大流行已成為全球醫療保健行業面臨的重大挑戰。 由於獲得醫療服務的機會有限,患有其他疾病的患者得不到治療。 腹腔鏡手術受到大流行的影響。 在此期間,手術可能會被取消甚至推遲,以降低病毒的傳播速度。 COVID-19 大流行對該地區的泌尿科護理和泌尿科醫生招聘產生了重大影響。 大流行期間對醫療保健系統的特殊影響改變了泌尿外科實踐,從而減緩了市場增長。
腹腔鏡部分預計將成為預測期內最大的部分
由於腹腔鏡能夠診斷腹部和骨盆內發生的各種情況,因此推測腹腔鏡部分有良好的生長。 該手術包括通過切口插入一根小管並通過該管泵送二氧化碳使胃膨脹,疼痛更小,患者更容易處理手術前後的壓力,也不太可能引起感染。相信這將推動市場的增長。
手術部分預計在預測期內的複合年增長率最高。
預計減肥手術部分在預測期內將呈現最快的複合年增長率,因為它是治療肥胖症的主要治療方法之一。 在這種手術中,胃的一部分被切除或使用胃束帶來縮小胃的大小。 世界範圍內兒童和青少年的肥胖率不斷上升,導致一些年輕患者接受了減肥手術。 減肥手術的增加可能會增加對一次性腹腔鏡設備的需求。
市場份額最高的地區
北美預計在預測期內佔據最大的市場份額。 促成該地區高速增長的因素包括肥胖症、各種慢性病的增加以及微創手術的日益普及。 此外,美國現有企業在各種手術設備方面的進步可能會推動北美市場的增長。
複合年增長率最高的地區
由於老年人口不斷增加以及胃腸道和腹部疾病的流行,預計歐洲在預測期內的複合年增長率最高。 此外,歐洲人病態肥胖發病率的急劇上升可能會增加該地區為減輕體重而進行的減肥手術的需求,從而推動腹腔鏡設備的增長。
主要發展
2022 年 12 月,美敦力 (Medtronic) 宣布第一位患者參加了 HUGO(TM) 機器人輔助手術系統的美國臨床試驗活動,疤痕更小。
2022 年 12 月,Stryker 將推出 Citrefix(TM) 縫合錨系統。 它採用屢獲殊榮的 Citregen 生物材料,旨在支持骨骼再生和自然癒合過程。
新系統使用 Citregen(TM),這是一種屢獲殊榮的生物可吸收材料,旨在模仿天然骨骼的化學和結構。
2022 年 11 月,美敦力 (Medtronic) 在美國推出全球首款也是唯一一款用於胰島素泵的輸液器,可將佩戴時間延長一倍,長達 7 天輸液器是將胰島素從胰島素泵輸送到體內的管子,因此通常需要更換每 2 到 3 天設置一次。
本報告的內容
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一。
According to Stratistics MRC, the Global Laparoscopic Instruments Market is accounted for $14.08 billion in 2022 and is expected to reach $31.73 billion by 2028 growing at a CAGR of 14.5% during the forecast period. Laparoscopic Instruments are the instruments that are used for surgical procedures that are performed through one or multiple small incisions, moderately than through a larger, typically single, incision through the abdominal wall with the help of a camera. Laparoscopic Instruments offer benefits of minimal invasion and less pain which heal faster and do not leave scars. Moreover, they provide better cosmesis, reduction in the rate of problems at the abdominal wall, shorter duration of hospitalization, and faster recommencement of daily life activities, use of these devices in surgical procedures ensure minimal bleeding and help in maintaining haemostasis.
According to a Ergie P.Inocian et al., published in Surgery for Obesity and Related Diseases Journal June 2021, there has been an increasing volume of bariatric surgeries in the Middle East to address obesity and metabolic disorders. Thus, bariatric surgical procedures continue to gain acceptance as a treatment for severe obesity in the Middle-East and North Africa regions, which is expected to impact market growth positively.
Market Dynamics:
Driver:
Rising inclination towards minimal invasive surgery over open surgery
The laparoscopic surgery is preferred more than usual surgeries owing to its abundant benefits, such as shorter hospital stay, decreased blood loss, and lower patient morbidity of laparoscopy, as well as providing quick recovery time, rapid and successful outcomes, low risk of infection, small or no incision and less pain. As the demand for laparoscopic surgery is drastically increasing, the demand for laparoscopic instruments is likely to also grow during the forecast period.
Restraint:
Lack of trained healthcare professionals
Laparoscopic surgery challenges the medical assistant control of surgeon visualization. There are increased levels of fatigue, technical errors, time to complete the surgery and instrument handling. This can also include infection, allergic reactions, damage to the organs, adhesions, blood clots, internal bleeding, in addition due to the reduced range of movement from tiny holes can be difficult. In some cases the unstable video camera platform, limited motion does not allow the surgeon to perform the surgery effectively, thus hampering the market growth.
Opportunity:
Change in lifestyle patterns
The factors driving the growth of the market are the increasing number of patients suffering from health issues such as uterine fibroids, and endometriosis, the rising number of hysterectomy and myomectomy procedures, and growing awareness about the improving healthcare infrastructure in emerging economies. Moreover instruments like medical laparoscopic robots, laparoscopes, laparoscopy reusable minimally invasive instruments, laparoscopic slide lock graspers, laparoscopic suction irrigation sets, and specialty laparoscopic instruments are propelling the market growth.
Threat:
Diminished infrastructure support for laparoscopic procedures in developing countries
However developing countries have a wide gap in the infrastructure available to support advanced medical procedures such as laparoscopy. The healthcare systems in developing countries are struggling to provide the infrastructure and resources to support advanced surgical techniques such as laparoscopic procedures which in turn reduces the number of laparoscopic procedures performed in these countries there by hindering the laparoscopic instruments market.
COVID-19 Impact
The COVID-19 pandemic has produced a significant challenge for the global healthcare industry. The Restricted access to medical services has led to insufficient care for patients suffering from other diseases. Laparoscopy has been adversely impacted by the pandemic. During this period, surgeries are often even cancelled or being postponed to the lower transmission of the virus. The COVID-19 pandemic has significantly impacted urological care and urologist recruitment in this region. The urology practice has been changed due to the exceptional impact on the healthcare system during the pandemic, hence reducing the market growth.
The Laparoscopes segment is expected to be the largest during the forecast period
The Laparoscopes segment is estimated to have a lucrative growth, due to its ability to diagnose a wide range of conditions that develop inside the abdomen or pelvis in which a small tube is inserted through the incision and carbon dioxide gas is pumped through the tube to inflate the stomach and performed as this procedure is less painful and easy for the patient to handle the pre and post operational stress with minimal infectious conditions are boosting the growth of the market.
The surgery segment is expected to have the highest CAGR during the forecast period
The bariatric surgery segment is anticipated to witness the fastest CAGR growth during the forecast period because it is one of the major treatment procedures for treating obesity. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are being witnessed across the globe, leading to several young patients undergoing bariatric surgery. The increasing bariatric surgical procedures are likely to raise the demand for disposable laparoscopic devices.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to The factors attributed to the region's high growth are the increasing cases of obesity, various chronic diseases, and the growing adoption of minimally-invasive surgeries. the high prevalence of chronic diseases in the country increases the demand for minimally invasive surgeries, thus, driving the laparoscopy devices market. Furthermore, advancements in various surgical devices from established players in the US are likely to drive market growth in North America.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to increase in geriatric population and prevalence of gastrointestinal & abdominal diseases in the region. In addition, rush in incidences of morbid obesity among the European population is likely to increase the demand for bariatric surgeries performed in the region for reducing weight, thereby boosting the growth of laparoscopy devices.
Key players in the market
Some of the key players profiled in the Laparoscopic Instruments Market include Medtronic, Stryker Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, CONMED Corporation, GENICON, INC., Karl Storz SE & CO., Johnson and Johnson, Applied Medical Resources Corporation, Microline Surgical, Mediflex-surgical-products.
Key Developments:
In Dec 2022, Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system e robotic-assisted prostatectomy procedure was performed by Dr. Michael R. Abern at Duke University Hospital in Durham, N.C. Minimally invasive surgery, including robotic-assisted surgery, offers fewer complications, shorter hospital stays, faster return to normal activities, and smaller scars.
In Dec 2022, Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.
In Nov 2022, Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.e. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
Product Types Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: